Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 277 contracts
Sources: Sales Agreement (AGNC Investment Corp.), Sales Agreement (Exscientia PLC), Sales Agreement (scPharmaceuticals Inc.)
Approval for Listing. The Either (i) the Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of First Placement Notice Date and Nasdaq shall have reviewed such application and not provided any Placement Noticeobjections thereto.
Appears in 106 contracts
Sources: Sales Agreement (XOMA Royalty Corp), Sales Agreement (BioAge Labs, Inc.), Sales Agreement (Quantum-Si Inc)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 36 contracts
Sources: Common Stock Sales Agreement (Editas Medicine, Inc.), Sales Agreement (Editas Medicine, Inc.), Sales Agreement (SpringWorks Therapeutics, Inc.)
Approval for Listing. The To the extent required by the rules of Nasdaq, the Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 21 contracts
Sources: Common Stock Sales Agreement (Edgewise Therapeutics, Inc.), Common Stock Sales Agreement (Edgewise Therapeutics, Inc.), Sales Agreement (Lyell Immunopharma, Inc.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on NasdaqNASDAQ, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq NASDAQ at, or prior to, the issuance of any Placement Notice.
Appears in 19 contracts
Sources: Sales Agreement (Oxford Immunotec Global PLC), Sales Agreement (Dermira, Inc.), Sales Agreement (AGNC Investment Corp.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of First Placement Notice Date and Nasdaq shall have reviewed such application and not provided any Placement Noticeobjections thereto.
Appears in 9 contracts
Sources: Sales Agreement (Axsome Therapeutics, Inc.), Sales Agreement (Arcturus Therapeutics Holdings Inc.), Sales Agreement (Axsome Therapeutics, Inc.)
Approval for Listing. The Placement Shares Securities shall either have been (i) approved for listing on NasdaqNasdaq Global Select Market, subject only to notice of issuance, or (ii) the Company shall have filed an application submitted to Nasdaq a notice of “Listing of Additional Shares” for listing of the Placement Shares Securities on the Nasdaq Global Select Market at, or prior to, the issuance of any Placement Notice.
Appears in 7 contracts
Sources: Equity Distribution Agreement (Oxford Lane Capital Corp.), Equity Distribution Agreement (Oxford Lane Capital Corp.), Equity Distribution Agreement (Oxford Lane Capital Corp.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement NoticeNotice and Nasdaq shall have reviewed such application and not provided any objections thereto.
Appears in 7 contracts
Sources: Sales Agreement (uniQure N.V.), Sales Agreement (uniQure N.V.), Sales Agreement (uniQure N.V.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement NoticeNotice and Nasdaq shall not have provided any objections thereto.
Appears in 6 contracts
Sources: At the Market Sales Agreement (Beyond Air, Inc.), Sales Agreement (Kura Oncology, Inc.), Sales Agreement (Beyond Air, Inc.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement NoticeNotice and Nasdaq shall not have raised any objection to such application.
Appears in 5 contracts
Sources: Sales Agreement (Syros Pharmaceuticals, Inc.), Sales Agreement (Global Blood Therapeutics, Inc.), Sales Agreement (Syros Pharmaceuticals, Inc.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on the Nasdaq Global Market at, or prior to, the issuance of any Placement Notice.
Appears in 4 contracts
Sources: Sales Agreement (Curis Inc), Capital on Demand Sales Agreement (Curis Inc), Sales Agreement (Curis Inc)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 4 contracts
Sources: Sales Agreement (AGNC Investment Corp.), At Market Issuance Sales Agreement (Intrusion Inc), At Market Issuance Sales Agreement (Audioeye Inc)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 4 contracts
Sources: Sales Agreement (Adverum Biotechnologies, Inc.), Sales Agreement (Greenlane Holdings, Inc.), Sales Agreement (Adverum Biotechnologies, Inc.)
Approval for Listing. The Placement Shares shall either have been been: (i) approved for listing on Nasdaq, subject only to notice of issuance, ; or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement NoticeNotice and Nasdaq shall not have provided any objections thereto.
Appears in 4 contracts
Sources: Sales Agreement (Electrameccanica Vehicles Corp.), Sales Agreement (Electrameccanica Vehicles Corp.), Sales Agreement (Electrameccanica Vehicles Corp.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on the Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on the Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 4 contracts
Sources: Sales Agreement (Dynavax Technologies Corp), Sales Agreement (Dynavax Technologies Corp), Sales Agreement (Dynavax Technologies Corp)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing filed, if required, a Listing of Additional Shares notification form with respect to the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 3 contracts
Sources: At Market Issuance Sales Agreement (CNB Financial Corp/Pa), At Market Issuance Sales Agreement (CNB Financial Corp/Pa), At Market Issuance Sales Agreement (City Holding Co)
Approval for Listing. The Placement Shares Securities shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for submitted a notification of listing of the Placement Shares Securities on the Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 3 contracts
Sources: Equity Distribution Agreement (Marin Software Inc), Equity Distribution Agreement (Marin Software Inc), Equity Distribution Agreement (Marin Software Inc)
Approval for Listing. The Either (i) the Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of First Placement Notice Date and Nasdaq shall not have provided any Placement Noticeobjections thereto.
Appears in 3 contracts
Sources: Sales Agreement (Schrodinger, Inc.), Sales Agreement (Schrodinger, Inc.), Sales Agreement (Schrodinger, Inc.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 3 contracts
Sources: Open Market Sale Agreement (Affimed N.V.), Open Market Sale Agreement (Affimed N.V.), Open Market Sale Agreement (Affimed N.V.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 3 contracts
Sources: Sales Agreement (Olema Pharmaceuticals, Inc.), Sales Agreement (Olema Pharmaceuticals, Inc.), Sales Agreement (Olema Pharmaceuticals, Inc.)
Approval for Listing. The Placement Shares Securities shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares Securities on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 2 contracts
Sources: Equity Distribution Agreement (Cree, Inc.), Equity Distribution Agreement (Genprex, Inc.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaqthe Nasdaq Global Market, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on the Nasdaq Global Market at, or prior to, the issuance of any Placement Notice.
Appears in 2 contracts
Sources: Sales Agreement (Cempra, Inc.), Sales Agreement (Cempra, Inc.)
Approval for Listing. The Placement Shares Securities shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares Securities on Nasdaq at, or prior to, the issuance of any Placement NoticeNotice and Nasdaq shall have reviewed such application and not provided any objection thereto.
Appears in 2 contracts
Sources: Equity Distribution Agreement (PLx Pharma Inc.), Equity Distribution Agreement (PLx Pharma Inc.)
Approval for Listing. The To the extent required by the rules of Nasdaq, the Placement Shares shall either have been (i) approved for listing on Nasdaq, Nasdaq subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 2 contracts
Sources: Sales Agreement (Brightcove Inc), Common Stock Sales Agreement (AppHarvest, Inc.)
Approval for Listing. The Placement Shares Securities shall either have been (i) approved for listing on the Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for submitted a notification of listing of the Placement Shares Securities on the Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 2 contracts
Sources: Equity Distribution Agreement (Icad Inc), Equity Distribution Agreement (Sorrento Therapeutics, Inc.)
Approval for Listing. The Either (i) the Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of First Placement Notice Date and Nasdaq shall have not provided any Placement Noticeobjections thereto.
Appears in 2 contracts
Sources: Sales Agreement (Nuvectis Pharma, Inc.), Sales Agreement (Benitec Biopharma Inc.)
Approval for Listing. The Placement Shares Securities shall either have been (i) approved for listing on Nasdaqthe Nasdaq Global Select Market, subject only to notice of issuance, or (ii) the Company shall have filed an application submitted to the Nasdaq Global Select Market a notice of “Listing of Additional Shares” for listing of the Placement Shares Securities on the Nasdaq Global Select Market at, or prior to, the issuance of any Placement Notice.
Appears in 2 contracts
Sources: Equity Distribution Agreement (Oxford Square Capital Corp.), Equity Distribution Agreement (Oxford Square Capital Corp.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on the Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on the Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 2 contracts
Sources: Sales Agreement (Indus Realty Trust, Inc.), Sales Agreement (Griffin Industrial Realty, Inc.)
Approval for Listing. The Placement Shares subject to a Placement Notice shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares subject to a Placement Notice on Nasdaq at, or prior to, the issuance of any such Placement Notice.
Appears in 2 contracts
Sources: Sales Agreement (SOPHiA GENETICS SA), Sales Agreement (SOPHiA GENETICS SA)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of taken the steps necessary to have the Placement Shares listed on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 2 contracts
Sources: Equity Distribution Agreement (DXP Enterprises Inc), Equity Distribution Agreement (DXP Enterprises Inc)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaqthe Nasdaq Market, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on the Nasdaq Market at, or prior to, the issuance of any Placement Notice.
Appears in 2 contracts
Sources: Sales Agreement (Generation Bio Co.), Sales Agreement (Generation Bio Co.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaqthe Nasdaq Global Market, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on the Nasdaq Global Market at, or prior to, the issuance of any Placement Notice.
Appears in 2 contracts
Sources: At Market Issuance Sales Agreement (Southern Missouri Bancorp, Inc.), At Market Issuance Sales Agreement (Unity Bancorp Inc /Nj/)
Approval for Listing. The Placement Shares Securities shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for submitted a notification of listing of the Placement Shares Securities on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 2 contracts
Sources: Equity Distribution Agreement (Aileron Therapeutics, Inc.), Equity Distribution Agreement (Idera Pharmaceuticals, Inc.)
Approval for Listing. The Placement Shares Securities shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for notified Nasdaq of the issuance and listing of the Placement Shares on Nasdaq at, or Securities prior to, to the issuance of any Placement NoticeNotice using the applicable Nasdaq form.
Appears in 2 contracts
Sources: Equity Distribution Agreement (Digimarc CORP), Equity Distribution Agreement (Digimarc CORP)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of First Placement Notice Date and Nasdaq shall have reviewed such applications and not provided any Placement Noticeobjections thereto.
Appears in 2 contracts
Sources: Sales Agreement (ZOOZ Power Ltd.), Sales Agreement (ZOOZ Power Ltd.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.. 28
Appears in 1 contract
Approval for Listing. The Either the Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of First Placement Notice Date and Nasdaq shall have reviewed such application and not provided any Placement Noticeobjections thereto.
Appears in 1 contract
Sources: Sales Agreement (InflaRx N.V.)
Approval for Listing. The Placement Shares Securities shall either have been (i) approved for listing on the Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares Securities on the Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 1 contract
Sources: Equity Distribution Agreement (Great Elm Capital Corp.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaqthe Nasdaq Capital Market, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on the Nasdaq Capital Market at, or prior to, the issuance of any Placement Notice.
Appears in 1 contract
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement NoticeNotice and, on the relevant Settlement Date, the Underlying Ordinary Shares underlying the Placement Shares shall have been approved for listing on Euronext, subject to official notice of issuance.
Appears in 1 contract
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq issuance at, or prior to, the issuance of any Placement Notice.
Appears in 1 contract
Approval for Listing. The Placement Shares Securities shall either have been (i) approved for listing on Nasdaqthe Nasdaq Capital Market, subject only to notice of issuance, or (ii) the Company shall have filed an application submitted to Nasdaq a notice of “Listing of Additional Shares” for listing of the Placement Shares Securities on the Nasdaq Capital Market at, or prior to, the issuance of any Placement Notice.
Appears in 1 contract
Sources: Equity Distribution Agreement (Herzfeld Caribbean Basin Fund Inc)
Approval for Listing. The Either (i) the Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any First Placement NoticeNotice Date.
Appears in 1 contract
Approval for Listing. The Placement To the extent required by the rules of Nasdaq, the Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 1 contract
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaqthe Exchange, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 1 contract
Sources: At Market Issuance Sales Agreement (Wireless Telecom Group Inc)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, and conditionally approved for listing on the TSX or (ii) in the case of Nasdaq, the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of First Placement Notice Date and Nasdaq shall have reviewed such application and not provided any Placement Noticeobjections thereto.
Appears in 1 contract
Approval for Listing. The Either (i) the Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of First Placement Notice Date and Nasdaq shall have reviewed such application and not provided any Placement Notice.objections thereto.
Appears in 1 contract
Sources: Equity Distribution Agreement (Y-mAbs Therapeutics, Inc.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaqthe Exchange, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on the Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 1 contract
Sources: Equity Distribution Agreement (American Realty Capital Properties, Inc.)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaqthe Nasdaq Global Select Market, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing filed, if required, a Listing of Additional Shares notification form with respect to the Placement Shares on the Nasdaq Global Select Market at, or prior to, the issuance of any Placement Notice.
Appears in 1 contract
Sources: At Market Issuance Sales Agreement (Lakeland Bancorp Inc)
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, issuance or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 1 contract
Approval for Listing. The If required, the Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 1 contract
Sources: Sales Agreement (NuCana PLC)
Approval for Listing. The Placement Shares Securities shall either have been (i) approved authorized for listing on the Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application a notice for listing of the Placement Shares Securities on the Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 1 contract
Approval for Listing. The Either (i) the Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing a Notification of Listing of Additional Shares with Nasdaq with respect to the Placement Shares on Nasdaq at, or prior to, the issuance of First Placement Notice Date and Nasdaq shall have not provided any Placement Noticeobjections thereto.
Appears in 1 contract
Approval for Listing. The Placement Shares shall either have been (i) approved for listing on NasdaqNYSE, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on the Nasdaq at, or prior to, the issuance of any Placement Notice.
Appears in 1 contract